Duncan

You might as well write your research in that way in the first place.

And in terms of the environmental things, copper surfaces and whatever else that Paul was talking about, are those kind of studies harder to do than a simple, not a simple, but an RCT of a drug, which is a kind of very obvious intervention?

So maybe some of these things that we're worrying about now are actually, you know, will help us next time round.

Now, Helen, you talked to him about the coordination from WHO and he also mentioned funders as well.

This reminds me of that story about why our p-value of 5.05 just pulled out of the air like that.

Next generation of EBMers.

Well, if you are a statistician and you do want to pick up on what Carl says, then if you go to bmj.com slash podcast, you can find out how to get in touch and maybe we will hear you on air next week.

Coming up in the future, we think we're going to be looking at a little bit more about the natural history of COVID.

We want to know about recovery.

We're going to be looking at some of the evidence about lockdown and how to get out of it in a sensible way.

So subscribe on Apple Podcasts or Spotify or wherever else you get your podcasts from.

Until then, it's goodbye from me.

Take care out there.